Medicare Enrolled

Dr. Binita Prajapati, DO

Family Medicine · West Orange, NJ
Low-engagement
405 NORTHFIELD AVE STE 105, West Orange, NJ 07052
9737938006
In practice since 2006 (19 years)
NPI: 1053324889 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Prajapati from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Prajapati? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Prajapati

Dr. Binita Prajapati is a family medicine specialist in West Orange, NJ, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Prajapati received a total of $7,213 from 45 pharmaceutical and/or device companies across 281 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Prajapati is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $7,213 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$7,213
Total received (2018-2024)
Avg $1,030/year across 7 years
Top 7% in NJ for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
281
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,334 (87.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$879 (12.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$952
2023
$1,540
2022
$1,309
2021
$1,495
2020
$241
2019
$761
2018
$914

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Intra-Sana Laboratories
$462
Novo Nordisk Inc
$206
Bayer Healthcare Pharmaceuticals Inc.
$82
ViiV Healthcare Company
$47
PFIZER INC.
$45
Gilead Sciences, Inc.
$28
Astellas Pharma US Inc
$21
Lilly USA, LLC
$17
ABBVIE INC.
$16
Rhythm Pharmaceuticals, Inc.
$15
AstraZeneca Pharmaceuticals LP
$14
Top 3 companies account for 78.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,521
Intra-Sana Laboratories
$1,341
Biohaven Pharmaceuticals, Inc.
$878
AstraZeneca Pharmaceuticals LP
$262
Biohaven Pharmaceutical Holding Company Ltd.
$260
Dexcom, Inc.
$241
Endo Pharmaceuticals Inc.
$198
Lilly USA, LLC
$171
Nevro Corp.
$144
Boehringer Ingelheim Pharmaceuticals, Inc.
$144
BOSTON SCIENTIFIC CORPORATION
$144
Janssen Pharmaceuticals, Inc
$142
Mannkind Corporation
$133
Amarin Pharma Inc.
$125
Insmed, Inc.
$117
Boston Scientific Corporation
$113
Teva Pharmaceuticals USA, Inc.
$107
SI-BONE, Inc.
$103
Vertiflex, Inc.
$100
Novartis Pharmaceuticals Corporation
$93
PFIZER INC.
$88
Stryker Corporation
$83
Bayer Healthcare Pharmaceuticals Inc.
$82
Abbott Laboratories
$60
Gilead Sciences, Inc.
$57
ViiV Healthcare Company
$47
ABBVIE INC.
$44
Merck Sharp & Dohme Corporation
$43
AbbVie Inc.
$42
DEXCOM, INC.
$33
Sunovion Pharmaceuticals Inc.
$33
Mission Pharmacal Company
$32
VIVUS LLC
$30
VIVUS, Inc.
$30
Amgen Inc.
$26
Astellas Pharma US Inc
$21
Sumitomo Pharma America, Inc.
$16
Rhythm Pharmaceuticals, Inc.
$15
Vertical Pharmaceuticals, LLC
$14
GlaxoSmithKline, LLC.
$14
Neurocrine Biosciences, Inc.
$14
kaleo, Inc.
$13
Sanofi Pasteur Inc.
$13
Exeltis, USA Inc.
$13
Optinose US, Inc.
$11
Top 3 companies account for 51.9% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AJOVY · APRETUDE · AUVI-Q · Arikayce · BREO · BREZTRI · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ELIQUIS · ENTRESTO · FARXIGA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 2 · FreeStyle Libre · GEMTESA · GENERAL PAIN MANAGEMENT · IMCIVREE · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LATUDA · LEQVIO · LONHALA MAGNAIR · LORZONE · MOUNJARO · NASCOBAL · NURTEC ODT · Ongentys · Otezla · Ozempic · PREVNAR 20 · QSYMIA · Qsymia · RELTONE 200 MG · RELTONE 400 MG · Rybelsus · SLYND · SPECTRA WAVEWRITER · SYMBICORT · Saxenda · Senza Spinal Cord Stimulation System · Superion ISS · TRADJENTA · TRITANIUM · TRULICITY · UBRELVY · Uribel · VRAYLAR · Vascepa · Veozah · Victoza · WATCHMAN · Wegovy · Xhance · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for family medicine in NJ.

Looking for a family medicine specialist in West Orange?
Compare family medicine physicians in the West Orange area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
2,927
Per 100K population
342.7
County median income
$76,712
Nearest hospital
HACKENSACK MERIDIAN MOUNTAINSIDE MEDICAL
3.1 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Prajapati is a family medicine specialist, with low-engagement industry engagement in the top 7% of NJ peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Prajapati receive payments from pharmaceutical companies?
Yes. Dr. Prajapati received a total of $7,213 from 45 companies across 281 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Prajapati) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in West Orange
Browse family medicine physicians in West Orange ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in NJ
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in NJ
Which NJ family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Intra-Sana Laboratories Payments to Doctors
See all physicians who received payments from Intra-Sana Laboratories.
By company
Biohaven Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceuticals, Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →